Conference Info

The Congress is designed to encourage dialogue around the following themes and related questions:

‘Contexts’ for Health

  • What constitutes a therapeutic environment?
  • How do we account for geo-cultural ‘best fit’ when engaging Morita therapy outside Japan?

Accounting for Culture in Assessment and Diagnosis

  • How can we account for the relationship between process, content and context in practice and research?
  • How do we interpret neurasthenia, shinkeishitsu, and other diagnostic categories inside and outside Japan?

Values Underlying Therapies

  • How much Zen is embedded in Morita Therapy?
  • How much Buddhism is embedded in Morita Therapy?
  • How urban-bound are some of our theories/methods of psychotherapy, such as ACT, CBT, MiCBT, and so on?

Therapeutic Methods and Processes

  • How do the stages of Morita therapy diminish symptoms of anxiety, dissociation, and symptoms of clinical and context-based depression over time and place?
  • How does ‘therapeutic alliance’ evolve during the course of Morita therapy?

Research Designs and Outcomes

  • What does ‘evidence-based’ mean (according to what methods and by support of what funding bodies -- where)?

Special Challenges for Therapeutic Response

  • Cancer patients and psycho-oncology
  • HIV positive and AIDS
  • Refugees and internally displaced people
  • War veterans and UN Peacekeepers
  • Victims/survivors of natural disasters
  • Youth issues (self harm, eating disorders, sexual-identity confusion)
  • Developmental challenges related to trauma (borderline features)
  • Therapy for the creative, bright & existentially generative client

Conference Working Committee

Chair and Associate Chair:

  • Peg LeVine, EdD, PhD (Chair of 7th Congress, Australia)
  • Naoki Watanabe, Kansai University of International Studies, Japan (Associate Chair of 7th Congress, Australia)

Advisory Board to the 7th Congress

  • Ishu Ishiyama, PhD (University of British Columbia, Canada)
  • Kenji Kitanishi, MD (President of Japan Morita Society; Professor at Japan Women’s University, Japan)
  • Toshihide Kuroki, MD, PhD (Hizen Psychiatric Center)
  • Kei Nakamura, MD (Jikei University and Director of Morita Therapy Center, Japan)
  • Shinichi Usa, MD (Sansei Hospital, Kyoto, Japan)
  • Marika Vicziany, PhD (Director, Monash Asia Institute, Australia)
  • Naoki Watanabe (Kansai University of International Studies, Japan)

Programming Congress Committee

  • Didier Bertrand, PhD (Director AFESIP, Lao PDR / Toulouse, France)
  • Di Clifton, MD (Director Psycho Oncology and Psychiatry)
  • Dr Lina Huot, MD (Psychiatrist, Cambodia)
  • Peg LeVine, EdD, PhD (Monash University, Australia)
  • Yoshimi Matsuda, PhD. (Australian Catholic University, Australia)
  • Brian Ogawa, DMin (Washburn University, USA)
  • Natalia Semyonova, PhD (Moscow Research Institute of Psychiatry, Russia)
  • Naoki Watanabe (Kansai University of International Studies, Japan)

LeKond Institute Secretariat Committee

  • Dianne Clifton, MD
  • Andrew Harris, MA, PhD candidate
  • Robert White, PhD candidate
  • John Mercer, PhD candidate
  • David Chong, MA
  • Peter O'Mara, arthouse consultant

Editorial Review Board

  • Di Clifton, MD
  • Andrew Harris, MA
  • Ishu Ishiyama, PhD
  • Christopher Ives, PhD (Professor of Religous Studies, Stonehill College)
  • Kenji Kitanishi, MD
  • Peg LeVine, EdD, PhD
  • Yoshimi Matsuda, PhD (Australian Catholic University, Australia)
  • Kei Nakamora, MD
  • Brian Ogawa, PhD
  • David Richards, PhD
  • Nancy Slater, PhD (Professor, Adler Institute Chicago)
  • Naoki Watanabe (Kansai University of International Studies, Japan)
     
    Morita

Support:
This conference is made possible by the support of the following contributors:

  • The Japan Morita Therapy Society, Japan
  • LeKond Institute (Morita Therapy Australia)
  • The Monash Asia Institute, Monash University, Australia
  • The Okamoto Mental Health Foundation, Japan

^ top of page